Form D · Biotechnology
PORTOLA PHARMACEUTICALS INC
South San Francisco, CA · CIK 0001269021
Offering snapshot reported Dec 21, 2011 · SEC filing
- Reported sold
- $9M Offering amount: $9M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 21, 2011 | Initial | $8,999,999 | No comparison | 1 | SEC filing |
| Dec 2, 2011 | Initial | $88,961,766 | No comparison | 56 | SEC filing |
| Jun 15, 2009 | Amendment | $60,099,999 | No comparison | 55 | SEC filing |
| Jul 21, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 12, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 11, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 23, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 28, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 2, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 18, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 3, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-170477
Source: Form D, filed Dec 21, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jean Jacques Bienaime | Director |
| Jeff Bird | Director |
| Farah Champsi | Director |
| Mardi Dier | Executive |
| Alan Frazier | Director |
| Nicholas Galakatos | Director |
| Jean George | Director |
| Pamela Green | Executive |
| Russell Hirsch | Director |
| Charles Homcy | Director |
| William Lis | Director, Executive |
| Peggy Phillips | Director |
| David R. Phillips | Executive |
| Hollings Renton | Director |
| James Topper | Director |
| Henry Ward Wolff | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
270 East Grand Avenue, Suite 22
South San Francisco, CA, 94080
South San Francisco, CA, 94080